Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 15:414:116888.
doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.

Myasthenic crisis in COVID-19

Fadi Delly  1 , Maryam J Syed  2 , Robert P Lisak  3 , Deepti Zutshi  4
Affiliations
Comment

Myasthenic crisis in COVID-19

Fadi Delly et al. J Neurol Sci. .

Abstract

  1. •

    Myasthenic crises is a potentially severe complication of COVID-19.

  2. •

    Hydroxychloroquine can aggravate myasthenia crises.

  3. •

    IVIg is a potential treatment for both Myasthenic crises and COVID-19.

  4. •

    IVIg treatment may cause thrombosis in susceptible patients.

Keywords: COVID-19; Myasthenia; Viral infection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Sequential chest radiographs of patient with COVID-19 and myasthenic crises.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94 doi: 10.1212/WNL.0000000000009455. Ahead of print. - DOI - PubMed
    1. Alberti P., Beretta S., Piatti M., Karantzoulis A., Piatti M.L., Santoro P., Vigano M., Giovannelli G., Pirro F., Montisano D.A., Appollonio I., Ferrarese C. Guillain-Barre syndrome related to COVID-19 infection. Neurol. Neuroimmunol. Neuroinflamm. 2020;7(4):741. doi: 10.1212/NXI.0000000000000741. - DOI - PMC - PubMed
    1. Guidon A.C., Amato A.A. COVID-19 and neuromuscular disorders. Neurology. 2020;94 doi: 10.1212/WNL.0000000000009566. Ahead of print. - DOI - PubMed
    1. M.G.C.-W.G. International, Jacob S., Muppidi S., Guidon A., Guptill J., Hehir M., Howard J.F., Jr., Illa I., Mantegazza R., Murai H., Utsugisawa K., Vissing J., Wiendl H., Nowak R.J. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J. Neurol. Sci. 2020;412:116803. doi: 10.1016/j.jns.2020.116803. - DOI - PMC - PubMed
    1. Gilhus N.E., Romi F., Hong Y., Skeie G.O. Myasthenia gravis and infectious disease. J. Neurol. 2018;265(6):1251–1258. doi: 10.1007/s00415-018-8751-9. - DOI - PubMed

LinkOut - more resources